Myelodysplastic syndrome with erythroblastopenia;Syndromes myélodysplasiques érythroblastopéniques

Revue de Medecine Interne

Volumn 32, Issue 1, 2011, Pages 33-38

  Martinaud, C ^a   Pons, S ^a   Menard G ^a   Gisserot, O ^a   de Jaureguiberry, J P ^a   Brisou, P ^a  

^a Military Teaching Hospital Sainte Anne   (France)

Author keywords

Erythroblastopenia; Myelodysplastic syndrome; Red cell aplasia

Indexed keywords

APLASTIC ANEMIA; ERYTHROBLASTOPENIA; ERYTHROCYTE APLASIA; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; GERIATRIC PATIENT; HIGH RISK PATIENT; HUMAN; MYELODYSPLASTIC SYNDROME; PROGNOSIS; PURE RED CELL ANEMIA; SEX DIFFERENCE; SHORT SURVEY; STEM CELL;

AGE DISTRIBUTION; BLOOD TRANSFUSION; DIAGNOSIS, DIFFERENTIAL; ERYTHROBLASTS; ERYTHROPOIETIN; EVIDENCE-BASED MEDICINE; FRANCE; HUMANS; MYELODYSPLASTIC SYNDROMES; PROGNOSIS; RED-CELL APLASIA, PURE; RISK FACTORS; SEX DISTRIBUTION;

EID: 78650562651     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2010.07.009     Document Type: Short Survey

References (45)

1. Vardiman J.W., Thiele J., Arber D.A., Brunning R.D., Borowitz M.J., Porwit A., et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009, 114:937-951.
2. Navarro I., Ruiz M.A., Cabello A., Collado R., Ferrer R., Hueso J., et al. Classification and scoring systems in myelodysplastic syndromes: a retrospective analysis of 311 patients. Leuk Res 2006, 30:971-977.
3. Merlat A, Picard F, Dreyfus F. Syndromes myélodysplasiques et leucémies secondaires. Encycl Méd Chir (Éditions Scientifiques et Médicales Elsevier SAS, Paris), Hématologie, 13-012-A-10, 2000, 14 p.
4. Aul C., Germing U., Gattermann N., Minning H. Increasing incidence of myelodysplastic syndromes: real or fictitious?. Leuk Res 1998, 22:93-100.
5. Fenaux P. Myelodysplastic syndromes. Hematol Cell Ther 1996, 38:363-380.
6. Park S., Merlat A., Guesnu M., Picard F., Viguie F., Vassilieff D., et al. Pure red cell aplasia associated with myelodysplastic syndromes. Leukemia 2000, 14:1709-1710.
7. Williamson P.J., Oscier D.G., Bell A.J., Hamblin T.J. Red cell aplasia in myelodysplastic syndrome. J Clin Pathol 1991, 44:431-432.
8. Wang S.A., Yue G., Hutchinson L., Landry M.L., Hasserjian R.P., Hao S., et al. Myelodysplastic syndrome with pure red cell aplasia shows characteristic clinicopathological features and clonal T-cell expansion. Br J Haematol 2007, 138:271-275.
9. Shimamoto T., Iguchi T., Ando K., Katagiri T., Tauchi T., Ito Y., et al. Successful treatment with cyclosporin A for myelodysplastic syndrome with erythroid hypoplasia associated with T-cell receptor gene rearrangements. Br J Haematol 2001, 114:358-361.
10. Barrett A.J., Sloand E. Autoimmune mechanisms in the pathophysiology of myelodysplastic syndromes and their clinical relevance. Haematologica 2009, 94:449-451.
11. Charles R.J., Sabo K.M., Kidd P.G., Abkowitz J.L. The pathophysiology of pure red cell aplasia: implications for therapy. Blood 1996, 87:4831-4838.
12. Lacombe C., Casadevall N., Muller O., Varet B. Erythroid progenitors in adult chronic pure red cell aplasia: relationship of in vitro erythroid colonies to therapeutic response. Blood 1984, 64:71-77.
13. Blagosklonny M.V. The dilemma of apoptosis in myelodysplasia and leukemia: a new promise of therapeutic intervention?. Leukemia 2000, 14:2017-2018.
14. Ghezzi P., Brines M. Erythropoietin as an antiapoptotic, tissue-protective cytokine. Cell Death Differ 2004, 11(Suppl. 1):S37-S44.
15. Hirokawa M., Sawada K., Fujishima N., Kawano F., Kimura A., Watanabe T., et al. Acquired pure red cell aplasia associated with malignant lymphomas: a nationwide cohort study in Japan for the PRCA Collaborative Study Group. Am J Hematol 2009, 84:144-148.
16. Konoplev S., Medeiros L.J., Lennon P.A., Prajapati S., Kanungo A., Lin P. Therapy may unmask hypoplastic myelodysplastic syndrome that mimics aplastic anemia. Cancer 2007, 110:1520-1526.
17. Kwong W.Y.A., Hawkins B.R., Cheng N., Lie A.K.W., Liang R.Y.L., Kwong Y.L. Risk of haematological malignancies in HLA-B27 carriers. Br J Haematol 2001, 115:320-322.
18. Saunthararajah Y., Nakamura R., Nam J.M., Robyn J., Loberiza F., Maciejewski J.P., et al. HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome. Blood 2002, 100:1570-1574.
19. Hofmann W.K., Koeffler H.P. Myelodysplastic syndrome. Annu Rev Med 2005, 56:1-16.
20. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A., Gralnick H.R., et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982, 51:189-199.
21. Bennett J.M. World Health Organization classification of the acute leukemias and myelodysplastic syndrome. Int J Hematol 2000, 72:131-133.
22. Abel GA, Bennekom CMV, Stone RM, Anderson TE, Kaufman DW. Classification of the myelodysplastic syndrome in a national registry of recently diagnosed patients. Leukemia Research 2010;34:939-41.
23. Keefer M.J., Solanki D.L. Dyserythropoiesis and erythroblast-phagocytosis preceding pure red cell aplasia. Am J Hematol 1988, 27:132-135.
24. Dumont J. Proceedings of the XV Congress of the International Society for Haematology. 1974; Jerusalem; 1974.
25. Fitchen J.H. Pure red cell aplasia: a pre-leukaemic state?. The preleukaemic syndrome 1985, 63-71. CRC, New York.
26. Jameel T., Anwar M., Abdi S.I., Saleem M., Ahmad P.A., Khattak M.F. Aplastic anemia or aplastic preleukemic syndrome?. Ann Hematol 1997, 75:189-193.
27. Clark D.A., Dessypris E.N., Krantz S.B. Studies on pure red cell aplasia. XI. Results of immunosuppressive treatment of 37 patients. Blood 1984, 63:277-286.
28. Greenberg P., Cox C., LeBeau M.M., Fenaux P., Morel P., Sanz G., et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997, 89:2079-2088.
29. Garcia-Suarez J., Pascual T., Munoz M.A., Herrero B., Pardo A. Myelodysplastic syndrome with erythroid hypoplasia/aplasia: a case report and review of the literature. Am J Hematol 1998, 58:319-325.
30. Go R.S., Li C.Y., Tefferi A., Phyliky R.L. Acquired pure red cell aplasia associated with lymphoproliferative disease of granular T lymphocytes. Blood 2001, 98:483-485.
31. Orazi A., Albitar M., Heerema N.A., Haskins S., Neiman R.S. Hypoplastic myelodysplastic syndromes can be distinguished from acquired aplastic anemia by CD34 and PCNA immunostaining of bone marrow biopsy specimens. Am J Clin Pathol 1997, 107:268-274.
32. Dincol G., Ozturk S., Palanduz S., Tutkan G., Yildirim N., Ayer M., et al. A case of myelodysplastic syndrome with erythroid hypoplasia associated with a familial translocation t(3;14)(p21,1;q24,1). Am J Hematol 2006, 81:883-887.
33. Casadevall N., Durieux P., Dubois S., Hemery F., Lepage E., Quarre M.C., et al. Health, economic, and quality-of-life effects of erythropoietin and granulocyte colony-stimulating factor for the treatment of myelodysplastic syndromes: a randomized, controlled trial. Blood 2004, 104:321-327.
34. Biesma D.H., van den Tweel J.G., Verdonck L.F. Immunosuppressive therapy for hypoplastic myelodysplastic syndrome. Cancer 1997, 79:1548-1551.
35. Molldrem J.J., Leifer E., Bahceci E., Saunthararajah Y., Rivera M., Dunbar C., et al. Antithymocyte globulin for treatment of the bone marrow failure associated with myelodysplastic syndromes. Ann Intern Med 2002, 137:156-163.
36. Gelsi-Boyer V., Vey N. Avancées dans la prise en charge des syndromes myélodysplasiques. Rev Med Interne 2006, 27:600-609.
37. Craig A., Geary C.G., Love E.M., Liu-Yin J. Red cell hypoplasia, thrombocytosis, and leucocytosis: myelodysplastic and proliferative syndrome. J Clin Pathol 1988, 41:1168-1170.
38. Cook M.K. Red cell hypoplasia associated with myeloproliferative and myelodysplastic syndrome. J Clin Pathol 1989, 42:890-891.
39. Lopez-Guillermo A., Cervantes F., Ribera J.M., Feliu E., Florensa L., Rozman C. Erythroblastopenia associated with chronic myelomonocytic leukemia. Sangre (Barc) 1989, 34:303-305.
40. Rodriguez Garcia J.A., Gil Garcia S. Erythroblastopenia associated with a myelodysplastic syndrome. Sangre (Barc) 1996, 41:260.
41. Kim H.D., Kim K.W., Park S.Y., Ko H.J., An Y.Y., Shin S.Y., et al. Myelodysplastic syndrome with erythroid aplasia following pure red cell aplasia. Korean J Intern Med 2004, 19:193-195.
42. Rawat S., Thakur R. Myelodysplasia with erythroid hypoplasia. Am J Hematol 2006, 81:557-558.
43. Kumar V., Dash S. Myelodysplastic syndrome with erythroid hypoplasia: a rare and distinct clincopathological entity - a report of two cases. Indian J Pathol Microbiol 2005, 48:36-37.
44. Goyal R., Varma N., Marwaha R.K. Myelodysplastic syndrome with erythroid hypoplasia. J Clin Pathol 2005, 58:320-321.
45. Uprichard J., Bain B.J. Case 39: an elderly man with red cell aplasia. Leuk Lymphoma 2008, 49:1810-1812.